XLV - Health Care Select Sector SPDR Fund
| Assets | $25.61B |
| NAV | $121.44 |
| Expense Ratio | 0.12% |
| PE Ratio | 18.49 |
| Beta (5Y) | 0.76 |
| Dividend (ttm) | $1.70 |
| Dividend Yield | 1.40% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $121.98 |
| Previous Close | $121.51 |
| Change ($) | 0.47 |
| Change (%) | 0.39% |
| Day's Open | 120.95 |
| Day's Range | 120.95 - 122.29 |
| Day's Volume | 7,934,712 |
| 52-Week Range | 93.93 - 122.29 |
Fund Description
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
| Asset Class Equity | Sector Biotech |
| Region North America | Inception Date Dec 16, 1998 |
| Exchange NYSEARCA | Ticker Symbol XLV |
| Index Tracked Health Care Select Sector Index | |
Top 10 Holdings
50.50% of assets| Name | Symbol | Weight |
|---|---|---|
| Johnson & Johnson | JNJ | 9.44% |
| UnitedHealth | UNH | 8.13% |
| Abbott Laboratories | ABT | 4.87% |
| Pfizer | PFE | 4.79% |
| Merck | MRK | 4.34% |
| Thermo Fisher Scientific | TMO | 4.24% |
| AbbVie | ABBV | 4.23% |
| Medtronic | MDT | 3.75% |
| Danaher | DHR | 3.39% |
| Eli Lilly | LLY | 3.33% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.397 | Mar 25, 2021 |
| Dec 21, 2020 | $0.464 | Dec 24, 2020 |
| Sep 21, 2020 | $0.418 | Sep 24, 2020 |
| Jun 22, 2020 | $0.425 | Jun 25, 2020 |
| Mar 23, 2020 | $0.382 | Mar 26, 2020 |
| Dec 30, 2019 | $1.331 | Jan 3, 2020 |
Cornerstone Macro's Carter Worth lays out his best pair trade idea
Cornerstone Macro's Carter Worth on whether the health care sector is ready to play catch up. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Dan Nathan.
Q2's winners will likely include selective, beaten-up FAANG and health care stocks, says BTIG's Eman
BTIG's Julian Emanuel on how to play the market in the second quarter. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Bonawyn Eison and Karen Finerman.
Eli Casdin on looking for opportunity in life sciences
Eli Casdin, Casdin Capital founder and CIO, on the top life sciences opportunities he sees in the markets, and how he decides which companies are good investments.
Hospitals make money on procedures, and HCA Healthcare is cheap and well-positioned to do just that.
The earnings expectations for the S&P 500 companies for Q2 is now a rise of 49.9% on 14.7% higher revenues.
Instead of buying shares in individual companies, these robust index funds with low fees enable you to invest in a basket of stocks. The post 8 of the Best Index Funds With Ultra-Low Fees appeared first...
Seasoned investors have historically loaded up on blue-chip stocks, and that's still true in 2021 The post 7 Blue-Chip Stocks That May Be Perfect For Retirement appeared first on InvestorPlace. More Fro...
Nearby levels of support and recent closes beyond key resistance are creating lucrative risk/reward setups in the healthcare sector.
Sectors with positive earnings growth in Q4 include autos (86.3% earnings growth), construction (27.2%), basic materials (7.6%), medical (6.3%), and aerospace (4.4%).
UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.
The healthcare sector spent ample time in the spotlight last year owing to the coronavirus pandemic. More of the same could be in store for the Health Care Select Sector SPDR ETF (NYSEArca: XLV) this ye...
While most of the ETFs have been surging over the past month, there are some hidden gems or Secret Santa as we call them that could surprise investors with big returns this Christmas based on the curren...
Health-care ETF XLV has risen nearly 10 percent in 2020
CNBC's Morgan Brennan reports on the rise of health care ETF XLV and what's driven the ETF higher.
The U.S. economy added 245,000 jobs in November, heavily easing from a downwardly revised 610,000 in October, and considerably below market expectations of 469,000.
Vaccine news this week has failed to give the health-care sector a lift. Mark Newton of Newton Advisors shares three charts that put the move into context.
These are the healthcare stocks with the best value, fastest growth, and most momentum for December 2020.
Ana Gupte of AG Health Advisors and Chris Meekins of Raymond James how to play possible health care
Ana Gupte, Principal at AG Health Advisors, and Chris Meekins, Health Care Policy Analyst at Raymond James, join Worldwide Exchange for a conversation about possible health care policies under a Biden a...
Markets started off November with the best election week performance since 1932. One of the best ways to invest in diverse exposure, or exposure to broader sectors is through ETFs.
The U.S. economy added 638,000 jobs in October 2020, easing from an upwardly revised 672,000 in the previous month.
Quint Tatro and JC O'Hara say these health-care names are poised for even more gains.
Health care is a fantastic place to be, but you have to stay long: Kevin O'Leary
Shark Tank star Kevin O'Leary has added more to his Pfizer holdings and says he is feeling bullish about the health-care sector. Jenny Harrington, CEO of Gilman Hill Asset Management also joins O'Leary ...
Congressional gridlock sharply lowers the odds for Medicare for All, new mandatory benefits, and drug price reform.
Health care companies are in very good shape long-term: Portfolio manager
CNBC's Kelly Evans talks with Les Funtleyder of E Squared Capital Management and Ana Gupte of AG Health Advisors about health care stocks surging and how they view pharma companies right now.
Jim Cramer lays out how to play health-care stocks after the 2020 election
CNBC's Jim Cramer runs down a list of health-care stocks that could be affected after the 2020 presidential election.
A Biden presidency would be better for health care: Jefferies equity strategist
Jared Holz, Jefferies health care equity strategist, joins 'Closing Bell' to discuss which presidency would be better for healthcare, why it would be better and more.
The healthcare sector is usually viewed as defensive, but that doesn't diminish the possibility that the Health Care Select Sector SPDR ETF (NYSEArca: XLV) will deliver some upbeat earnings news when re...
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
Look for growth opportunities in health care, technology and e-commerce: Investing pro
Doug Sandler, Riverfront Investment Group's head of global strategy, and Kevin Mahn, Hennion and Walsh Asset Management president and CIO, joins CNBC's "Power Lunch" to discuss whether the vaccine or th...
The winner, when the dust settles on Nov. 3 (or after), may affect ETFs in varying ways.
Nancy Tengler: Overweight healthcare, consumer discretionary, industrials
Nancy Tengler, Laffer Tengler investments CIO, joins 'Closing Bell' to talk about where she's adding as uncertainty continues in the markets.
In terms of financial market seasonality, October is an interesting month. The tenth month is known to have given birth to some of the most dramatic market declines, but over the past two decades, the S...
Health care is again at a political crossroads heading into the U.S. presidential election. Gina Sanchez of Chantico Global and Craig Johnson of Piper Sandler discuss the potential winners and losers in...
Justice Ruth Bader Ginsburg's death jeopardizes Obamacare's future, and that puts healthcare companies' revenue at risk.
Hospital stocks hit as RBG's death puts future of health care in question
Ana Gupte, AG Health Advisors, speaks with CNBC's "Fast Money" about the future of the Affordable Care Act following the death of Supreme Court Justice Ruth Bader Ginsburg.
The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.